Delivery Order SPE2DB20D1100-SPE2DB24FA1J8
Award Date
2/7/24
Potential Completion Date
2/8/24
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The award, valued at $15,164.66, is a Firm Fixed Price delivery order contract with a completion date of January 19, 2024. The contract covers the procurement of a specific medical product, "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML," with no set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,504.80, is for the delivery of pharmaceutical products, including the drug ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,707.60 firm fixed-price delivery order is for the medical product "ZEPBOUND 15 MG/0.5 ML PEN 0.5ML" and has a completion date of February 9, 2024. The contract has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,301.00 firm fixed-price delivery order covers the supply of the pharmaceutical product ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,360.80 delivery order is for the medical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has a period of performance through February 27, 2024. The contract is a firm fixed price delivery order, indicating the government procured a specific quantity of the product at a pre-determined price. This award is not associated with a set-aside...
This federal contract award, valued at $2,014.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the...
This federal contract award, valued at $25,222.68, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563664766 ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,344.91, is for the delivery of pharmaceutical products, including the drug ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is February 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,207.12 delivery order contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a period of performance through February 13, 2024 and uses a firm fixed price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $5,197.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the medication ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...